CASRN	CTD_CHEM2DISEASE|Adenoma	CTD_CHEM2DISEASE|Carcinoma	CTD_CHEM2DISEASE|Carcinoma, Hepatocellular	CTD_CHEM2DISEASE|Esophageal Neoplasms	CTD_CHEM2DISEASE|Hyperplasia	CTD_CHEM2DISEASE|Liver Neoplasms, Experimental	CTD_CHEM2DISEASE|Lung Neoplasms	CTD_CHEM2GENE_25|AXIN2	CTD_CHEM2GENE_25|CAT	CTD_CHEM2GENE_25|CYP2A13	CTD_CHEM2GENE_25|TPO	CTD_CHEMICALS_DISEASES|ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO	CTD_CHEMICALS_DISEASES|Abnormalities, Drug-Induced	CTD_CHEMICALS_DISEASES|Acatalasia	CTD_CHEMICALS_DISEASES|Acquired Hyperostosis Syndrome	CTD_CHEMICALS_DISEASES|Acute Lung Injury	CTD_CHEMICALS_DISEASES|Adenocarcinoma	CTD_CHEMICALS_DISEASES|Adenocarcinoma of Lung	CTD_CHEMICALS_DISEASES|Alcoholism	CTD_CHEMICALS_DISEASES|Amino Acid Metabolism, Inborn Errors	CTD_CHEMICALS_DISEASES|Amyotrophic lateral sclerosis 1	CTD_CHEMICALS_DISEASES|Aortic Diseases	CTD_CHEMICALS_DISEASES|Arthritis, Experimental	CTD_CHEMICALS_DISEASES|Arthritis, Juvenile	CTD_CHEMICALS_DISEASES|Arthritis, Rheumatoid	CTD_CHEMICALS_DISEASES|Ascorbic Acid Deficiency	CTD_CHEMICALS_DISEASES|Asphyxia Neonatorum	CTD_CHEMICALS_DISEASES|Asthma	CTD_CHEMICALS_DISEASES|Autistic Disorder	CTD_CHEMICALS_DISEASES|Autoimmune Diseases	CTD_CHEMICALS_DISEASES|Behcet Syndrome	CTD_CHEMICALS_DISEASES|Bone Diseases, Developmental	CTD_CHEMICALS_DISEASES|Brain Ischemia	CTD_CHEMICALS_DISEASES|Breast Neoplasms	CTD_CHEMICALS_DISEASES|Brunner Syndrome	CTD_CHEMICALS_DISEASES|Carcinoma	CTD_CHEMICALS_DISEASES|Carcinoma, Ductal	CTD_CHEMICALS_DISEASES|Carcinoma, Hepatocellular	CTD_CHEMICALS_DISEASES|Carcinoma, Merkel Cell	CTD_CHEMICALS_DISEASES|Carcinoma, Non-Small-Cell Lung	CTD_CHEMICALS_DISEASES|Carcinoma, Renal Cell	CTD_CHEMICALS_DISEASES|Carcinoma, Squamous Cell	CTD_CHEMICALS_DISEASES|Carcinoma, Transitional Cell	CTD_CHEMICALS_DISEASES|Cardiomegaly	CTD_CHEMICALS_DISEASES|Cardiomyopathy, Dilated	CTD_CHEMICALS_DISEASES|Celiac Disease	CTD_CHEMICALS_DISEASES|Cell Transformation, Neoplastic	CTD_CHEMICALS_DISEASES|Chemical and Drug Induced Liver Injury	CTD_CHEMICALS_DISEASES|Cholestasis	CTD_CHEMICALS_DISEASES|Chondrosarcoma, Mesenchymal	CTD_CHEMICALS_DISEASES|Chromosome Breakage	CTD_CHEMICALS_DISEASES|Cleft Lip	CTD_CHEMICALS_DISEASES|Cleft Palate	CTD_CHEMICALS_DISEASES|Colonic Neoplasms	CTD_CHEMICALS_DISEASES|Colorectal Neoplasms	CTD_CHEMICALS_DISEASES|Congenital Hypothyroidism	CTD_CHEMICALS_DISEASES|Congenital disorder of glycosylation type 1G	CTD_CHEMICALS_DISEASES|Copper-Overload Cirrhosis	CTD_CHEMICALS_DISEASES|Coronary Disease	CTD_CHEMICALS_DISEASES|Corticosteroid-Binding Globulin Deficiency	CTD_CHEMICALS_DISEASES|Dermatitis, Contact	CTD_CHEMICALS_DISEASES|Diabetes Mellitus	CTD_CHEMICALS_DISEASES|Diabetes Mellitus, Experimental	CTD_CHEMICALS_DISEASES|Diabetes Mellitus, Type 1	CTD_CHEMICALS_DISEASES|Diabetes Mellitus, Type 2	CTD_CHEMICALS_DISEASES|Diabetic Neuropathies	CTD_CHEMICALS_DISEASES|Diarrhea 5, With Tufting Enteropathy, Congenital	CTD_CHEMICALS_DISEASES|Disease Models, Animal	CTD_CHEMICALS_DISEASES|Disease Progression	CTD_CHEMICALS_DISEASES|Drug Eruptions	CTD_CHEMICALS_DISEASES|Drug-Related Side Effects and Adverse Reactions	CTD_CHEMICALS_DISEASES|Dyskinesia, Drug-Induced	CTD_CHEMICALS_DISEASES|Dystonia musculorum deformans type 1	CTD_CHEMICALS_DISEASES|ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1	CTD_CHEMICALS_DISEASES|Edema	CTD_CHEMICALS_DISEASES|Endometrial Neoplasms	CTD_CHEMICALS_DISEASES|Endometriosis	CTD_CHEMICALS_DISEASES|Enterocolitis, Necrotizing	CTD_CHEMICALS_DISEASES|Esophageal Neoplasms	CTD_CHEMICALS_DISEASES|Esophageal Squamous Cell Carcinoma	CTD_CHEMICALS_DISEASES|Fatty Liver	CTD_CHEMICALS_DISEASES|Fatty Liver, Alcoholic	CTD_CHEMICALS_DISEASES|Fetal Alcohol Spectrum Disorders	CTD_CHEMICALS_DISEASES|Genetic Predisposition to Disease	CTD_CHEMICALS_DISEASES|Glioblastoma	CTD_CHEMICALS_DISEASES|Glioma	CTD_CHEMICALS_DISEASES|Goiter	CTD_CHEMICALS_DISEASES|Guanidinoacetate methyltransferase deficiency	CTD_CHEMICALS_DISEASES|HHH syndrome	CTD_CHEMICALS_DISEASES|HIV Infections	CTD_CHEMICALS_DISEASES|HYPEROXALURIA, PRIMARY, TYPE III	CTD_CHEMICALS_DISEASES|Heart Failure	CTD_CHEMICALS_DISEASES|Hemangiosarcoma	CTD_CHEMICALS_DISEASES|Hepatitis, Chronic	CTD_CHEMICALS_DISEASES|Hepatolenticular Degeneration	CTD_CHEMICALS_DISEASES|Hypercalcemia, Infantile	CTD_CHEMICALS_DISEASES|Hyperplasia	CTD_CHEMICALS_DISEASES|Hypertension	CTD_CHEMICALS_DISEASES|Hyperthyroidism	CTD_CHEMICALS_DISEASES|Hypertrophy	CTD_CHEMICALS_DISEASES|Hypertrophy, Left Ventricular	CTD_CHEMICALS_DISEASES|Hypotension	CTD_CHEMICALS_DISEASES|INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY	CTD_CHEMICALS_DISEASES|Idiopathic Pulmonary Fibrosis	CTD_CHEMICALS_DISEASES|Inherited Peripheral Neuropathy	CTD_CHEMICALS_DISEASES|Intestinal Neoplasms	CTD_CHEMICALS_DISEASES|Keratosis	CTD_CHEMICALS_DISEASES|Kidney Diseases	CTD_CHEMICALS_DISEASES|Kidney Failure, Chronic	CTD_CHEMICALS_DISEASES|Kidney Neoplasms	CTD_CHEMICALS_DISEASES|LYMPHATIC MALFORMATION 4	CTD_CHEMICALS_DISEASES|Laryngo onycho cutaneous syndrome	CTD_CHEMICALS_DISEASES|Leukemia	CTD_CHEMICALS_DISEASES|Leukemia, Myeloid, Acute	CTD_CHEMICALS_DISEASES|Limb-Girdle Muscular Dystrophy, Type 1G	CTD_CHEMICALS_DISEASES|Liver Cirrhosis, Alcoholic	CTD_CHEMICALS_DISEASES|Liver Cirrhosis, Experimental	CTD_CHEMICALS_DISEASES|Liver Neoplasms	CTD_CHEMICALS_DISEASES|Liver Neoplasms, Experimental	CTD_CHEMICALS_DISEASES|Lung Neoplasms	CTD_CHEMICALS_DISEASES|Lupus Erythematosus, Systemic	CTD_CHEMICALS_DISEASES|Lymphoma, Large B-Cell, Diffuse	CTD_CHEMICALS_DISEASES|Lymphoma, Mantle-Cell	CTD_CHEMICALS_DISEASES|Lymphoma, Non-Hodgkin	CTD_CHEMICALS_DISEASES|Macular Degeneration, Age-Related, 9	CTD_CHEMICALS_DISEASES|Marfan Syndrome	CTD_CHEMICALS_DISEASES|Marijuana Abuse	CTD_CHEMICALS_DISEASES|Meconium Ileus	CTD_CHEMICALS_DISEASES|Medulloblastoma	CTD_CHEMICALS_DISEASES|Melanoma	CTD_CHEMICALS_DISEASES|Mesothelioma	CTD_CHEMICALS_DISEASES|Mesothelioma, Malignant	CTD_CHEMICALS_DISEASES|Methylmalonate Semialdehyde Dehydrogenase Deficiency	CTD_CHEMICALS_DISEASES|Micronuclei, Chromosome-Defective	CTD_CHEMICALS_DISEASES|Mitochondrial myopathy with lactic acidosis	CTD_CHEMICALS_DISEASES|Mucolipidosis III Gamma	CTD_CHEMICALS_DISEASES|Multiple Mitochondrial Dysfunctions Syndrome	CTD_CHEMICALS_DISEASES|Muscular Dystrophy, Facioscapulohumeral	CTD_CHEMICALS_DISEASES|Myelodysplastic Syndromes	CTD_CHEMICALS_DISEASES|Myocardial Infarction	CTD_CHEMICALS_DISEASES|Myocardial Ischemia	CTD_CHEMICALS_DISEASES|Myocardial Reperfusion Injury	CTD_CHEMICALS_DISEASES|NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	CTD_CHEMICALS_DISEASES|NEPHROTIC SYNDROME, TYPE 8	CTD_CHEMICALS_DISEASES|Nasopharyngeal Carcinoma	CTD_CHEMICALS_DISEASES|Necrosis	CTD_CHEMICALS_DISEASES|Neoplasm Invasiveness	CTD_CHEMICALS_DISEASES|Neoplasm Metastasis	CTD_CHEMICALS_DISEASES|Neoplasms	CTD_CHEMICALS_DISEASES|Neuroblastoma	CTD_CHEMICALS_DISEASES|Neurodevelopmental Disorders	CTD_CHEMICALS_DISEASES|Neuroectodermal Tumors	CTD_CHEMICALS_DISEASES|Neuropathy, Distal Hereditary Motor, Type IIA	CTD_CHEMICALS_DISEASES|Nevus	CTD_CHEMICALS_DISEASES|Non-alcoholic Fatty Liver Disease	CTD_CHEMICALS_DISEASES|Obesity	CTD_CHEMICALS_DISEASES|Oligodontia-Colorectal Cancer Syndrome	CTD_CHEMICALS_DISEASES|Optic atrophy 1 and deafness	CTD_CHEMICALS_DISEASES|Osteoarthritis	CTD_CHEMICALS_DISEASES|Osteogenesis imperfecta, type 6	CTD_CHEMICALS_DISEASES|Osteopetrosis with renal tubular acidosis	CTD_CHEMICALS_DISEASES|Osteoporosis, Postmenopausal	CTD_CHEMICALS_DISEASES|Osteosarcoma	CTD_CHEMICALS_DISEASES|Ovarian Neoplasms	CTD_CHEMICALS_DISEASES|PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE	CTD_CHEMICALS_DISEASES|PARKINSON DISEASE 17	CTD_CHEMICALS_DISEASES|PEROXISOME BIOGENESIS DISORDER 4B	CTD_CHEMICALS_DISEASES|Pancreatic Neoplasms	CTD_CHEMICALS_DISEASES|Panniculitis, Nodular Nonsuppurative	CTD_CHEMICALS_DISEASES|Papilloma	CTD_CHEMICALS_DISEASES|Paratuberculosis	CTD_CHEMICALS_DISEASES|Parkinson Disease	CTD_CHEMICALS_DISEASES|Penttinen-Aula syndrome	CTD_CHEMICALS_DISEASES|Periodic fever, familial, autosomal dominant	CTD_CHEMICALS_DISEASES|Peripheral Nervous System Diseases	CTD_CHEMICALS_DISEASES|Peroxisome biogenesis disorders	CTD_CHEMICALS_DISEASES|Phobic Disorders	CTD_CHEMICALS_DISEASES|Polycystic Kidney, Autosomal Dominant	CTD_CHEMICALS_DISEASES|Polycystic liver disease	CTD_CHEMICALS_DISEASES|Polyglucosan Body Disease, Adult Form	CTD_CHEMICALS_DISEASES|Pontocerebellar Hypoplasia Type 1	CTD_CHEMICALS_DISEASES|Porphyria, Variegate	CTD_CHEMICALS_DISEASES|Precancerous Conditions	CTD_CHEMICALS_DISEASES|Precursor Cell Lymphoblastic Leukemia-Lymphoma	CTD_CHEMICALS_DISEASES|Premature Birth	CTD_CHEMICALS_DISEASES|Prostate cancer, familial	CTD_CHEMICALS_DISEASES|Prostatic Intraepithelial Neoplasia	CTD_CHEMICALS_DISEASES|Prostatic Neoplasms	CTD_CHEMICALS_DISEASES|Protein Deficiency	CTD_CHEMICALS_DISEASES|Psoriasis	CTD_CHEMICALS_DISEASES|Pulmonary Edema	CTD_CHEMICALS_DISEASES|Pulmonary Embolism	CTD_CHEMICALS_DISEASES|Pulmonary Emphysema	CTD_CHEMICALS_DISEASES|Pulmonary Fibrosis	CTD_CHEMICALS_DISEASES|Reperfusion Injury	CTD_CHEMICALS_DISEASES|Rhinitis, Allergic	CTD_CHEMICALS_DISEASES|SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE	CTD_CHEMICALS_DISEASES|SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE	CTD_CHEMICALS_DISEASES|Salivary Gland Neoplasms	CTD_CHEMICALS_DISEASES|Schizophrenia	CTD_CHEMICALS_DISEASES|Seizures	CTD_CHEMICALS_DISEASES|Snyder Robinson syndrome	CTD_CHEMICALS_DISEASES|Spastic Paraplegia 7, Autosomal Recessive	CTD_CHEMICALS_DISEASES|Spinocerebellar Ataxia 17	CTD_CHEMICALS_DISEASES|Spondyloepimetaphyseal dysplasia, Genevieve type	CTD_CHEMICALS_DISEASES|Squamous Cell Carcinoma of Head and Neck	CTD_CHEMICALS_DISEASES|Status Epilepticus	CTD_CHEMICALS_DISEASES|Stomach Neoplasms	CTD_CHEMICALS_DISEASES|Stomach Ulcer	CTD_CHEMICALS_DISEASES|Sudden Infant Death with Dysgenesis of the Testes Syndrome	CTD_CHEMICALS_DISEASES|THIOPURINES, POOR METABOLISM OF, 2	CTD_CHEMICALS_DISEASES|TOOTH AGENESIS, SELECTIVE, 9	CTD_CHEMICALS_DISEASES|Thyroid Dyshormonogenesis 2A	CTD_CHEMICALS_DISEASES|Turner Syndrome	CTD_CHEMICALS_DISEASES|Ureteral Calculi	CTD_CHEMICALS_DISEASES|Urinary Bladder Neoplasms	CTD_CHEMICALS_DISEASES|Urologic Neoplasms	CTD_CHEMICALS_DISEASES|Uterine Cervical Neoplasms	CTD_CHEMICALS_DISEASES|VERHEIJ SYNDROME	CTD_CHEMICALS_DISEASES|VLCAD deficiency	CTD_CHEMICALS_DISEASES|Ventricular Remodeling	CTD_CHEMICALS_DISEASES|Weight Loss	CTD_CHEMICALS_DISEASES|Wolf-Hirschhorn Syndrome	CTD_CHEMICALS_DISEASES|Zellweger Syndrome	CTD_CHEMICALS_GENES|AXIN2;CYP2A13;FMO1;FMO2;MYC;PYGO2;TCF7L2	CTD_CHEMICALS_GENES|CAT	CTD_CHEMICALS_GENES|CDKN1A;MDM2;MKI67;TPO	CTD_CHEMICALS_GENES|CYP2A13;CYP2E1	CTD_CHEMICALS_GENES|ID4;SERPINF1;PDCD4;CIAO1;CTDSP2;MAOA;CRELD2;COL18A1;GSTP1;CYSTM1;DNAJC30;SPG7;PPID;HRAS;CCDC28A;SLC25A15;URAD;EIF4E;ABHD5;AKR1E2;ST7L;LCLAT1;AKT2;MRPL46;ZFP36L1	CTD_CHEMICALS_GOENRICH_CELLCOMP|GO:0005622|intracellular;GO:0044424|intracellular part;GO:0005737|cytoplasm;GO:0005623|cell;GO:0044464|cell part;GO:0044444|cytoplasmic part;GO:0043226|organelle;GO:0043229|intracellular organelle;GO:0043227|membrane-bounded organelle;GO:0043231|intracellular membrane-bounded organelle;GO:0044446|intracellular organelle part;GO:0044422|organelle part;GO:0005829|cytosol;GO:0031974|membrane-enclosed lumen;GO:0043233|organelle lumen;GO:0070013|intracellular organelle lumen;GO:0032991|protein-containing complex;GO:0005634|nucleus;GO:0005739|mitochondrion;GO:0016020|membrane;GO:0012505|endomembrane system;GO:0005654|nucleoplasm;GO:0044428|nuclear part;GO:0031981|nuclear lumen;GO:0044429|mitochondrial part;GO:0031090|organelle membrane;GO:0031967|organelle envelope;GO:0031975|envelope;GO:0005740|mitochondrial envelope;GO:0031966|mitochondrial membrane;GO:0044425|membrane part;GO:0043232|intracellular non-membrane-bounded organelle;GO:0043228|non-membrane-bounded organelle;GO:0031982|vesicle;GO:0005783|endoplasmic reticulum;GO:0005743|mitochondrial inner membrane;GO:0031410|cytoplasmic vesicle;GO:0097708|intracellular vesicle;GO:0005759|mitochondrial matrix;GO:0019866|organelle inner membrane;GO:0034774|secretory granule lumen;GO:0030141|secretory granule;GO:0098798|mitochondrial protein complex;GO:0060205|cytoplasmic vesicle lumen;GO:0031983|vesicle lumen;GO:0044432|endoplasmic reticulum part;GO:0071944|cell periphery;GO:0099503|secretory vesicle;GO:0005576|extracellular region;GO:1990904|ribonucleoprotein complex;GO:0005886|plasma membrane;GO:0031984|organelle subcompartment;GO:0031224|intrinsic component of membrane;GO:1902494|catalytic complex;GO:0044433|cytoplasmic vesicle part;GO:0016021|integral component of membrane;GO:0044455|mitochondrial membrane part;GO:1904813|ficolin-1-rich granule lumen;GO:0101002|ficolin-1-rich granule;GO:0005856|cytoskeleton;GO:0098588|bounding membrane of organelle;GO:0005789|endoplasmic reticulum membrane;GO:0098827|endoplasmic reticulum subcompartment;GO:0042175|nuclear outer membrane-endoplasmic reticulum membrane network;GO:0005794|Golgi apparatus;GO:0005788|endoplasmic reticulum lumen;GO:0015630|microtubule cytoskeleton;GO:0042995|cell projection;GO:0120025|plasma membrane bounded cell projection;GO:0005615|extracellular space;GO:0000313|organellar ribosome;GO:0005761|mitochondrial ribosome;GO:0098796|membrane protein complex;GO:0044421|extracellular region part;GO:0048471|perinuclear region of cytoplasm;GO:0044451|nucleoplasm part;GO:0098805|whole membrane;GO:0042470|melanosome;GO:0048770|pigment granule;GO:0016604|nuclear body;GO:0005681|spliceosomal complex;GO:0005819|spindle;GO:0005730|nucleolus	CTD_CHEMICALS_GOENRICH_MOLFUNCT|GO:0005488|binding;GO:0005515|protein binding;GO:0003824|catalytic activity;GO:0043167|ion binding;GO:0097159|organic cyclic compound binding;GO:1901363|heterocyclic compound binding;GO:0042802|identical protein binding;GO:0016787|hydrolase activity;GO:0016491|oxidoreductase activity;GO:0036094|small molecule binding;GO:0019899|enzyme binding;GO:0016740|transferase activity;GO:0043168|anion binding;GO:0000166|nucleotide binding;GO:1901265|nucleoside phosphate binding;GO:0048037|cofactor binding;GO:0050662|coenzyme binding;GO:0043169|cation binding;GO:0140096|catalytic activity, acting on a protein;GO:0030234|enzyme regulator activity;GO:0046872|metal ion binding;GO:0044877|protein-containing complex binding;GO:0098772|molecular function regulator;GO:0097367|carbohydrate derivative binding;GO:0051082|unfolded protein binding;GO:0019901|protein kinase binding;GO:0019900|kinase binding;GO:0008144|drug binding;GO:0016765|transferase activity, transferring alkyl or aryl (other than methyl) groups;GO:0032555|purine ribonucleotide binding;GO:0017076|purine nucleotide binding;GO:0032553|ribonucleotide binding;GO:0035639|purine ribonucleoside triphosphate binding;GO:0016772|transferase activity, transferring phosphorus-containing groups;GO:0032559|adenyl ribonucleotide binding;GO:0050660|flavin adenine dinucleotide binding;GO:0030554|adenyl nucleotide binding;GO:0046983|protein dimerization activity;GO:0016788|hydrolase activity, acting on ester bonds;GO:0005524|ATP binding;GO:0042803|protein homodimerization activity;GO:0005102|signaling receptor binding;GO:0009055|electron transfer activity;GO:0031625|ubiquitin protein ligase binding;GO:0016616|oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;GO:0016462|pyrophosphatase activity;GO:0016817|hydrolase activity, acting on acid anhydrides;GO:0016818|hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;GO:0044389|ubiquitin-like protein ligase binding;GO:0016614|oxidoreductase activity, acting on CH-OH group of donors;GO:0008289|lipid binding;GO:0003676|nucleic acid binding;GO:0061134|peptidase regulator activity;GO:0016301|kinase activity;GO:0017111|nucleoside-triphosphatase activity	CTD_CHEMICALS_PATHWAYS|REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5389840|Mitochondrial translation elongation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-5368287|Mitochondrial translation;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-5619115|Disorders of transmembrane transporters;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-1483206|Glycerophospholipid biosynthesis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;REACT:R-HSA-5419276|Mitochondrial translation termination;REACT:R-HSA-5368286|Mitochondrial translation initiation;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-15869|Metabolism of nucleotides;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);KEGG:hsa01200|Carbon metabolism;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-68886|M Phase;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-69242|S Phase;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa03040|Spliceosome;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN	CTD_PATHWAY|KEGG:00982|Drug metabolism - cytochrome P450	HTS_ACTIVE|activation_AP1	HTS_ACTIVE|activation_ATAD5	HTS_ACTIVE|activation_H2AX	HTS_ACTIVE|activation_Nrf2	HTS_ACTIVE|agonism_AR/full	HTS_ACTIVE|agonism_AhR	HTS_ACTIVE|agonism_ER/full	HTS_ACTIVE|agonism_RSP	HTS_ACTIVE|antagonism_AR/full/run1	HTS_ACTIVE|antagonism_AR/full/run2	HTS_ACTIVE|antagonism_AR/partial	HTS_ACTIVE|antagonism_ER/partial	HTS_ACTIVE|antagonism_GR	HTS_ACTIVE|antagonism_RORr	HTS_ACTIVE|antagonism_TR	HTS_ACTIVE|antagonism_VDR	HTS_ACTIVE|cytotoxicity_AR/antagonism/full/run1	HTS_ACTIVE|cytotoxicity_AR/antagonism/full/run2	HTS_ACTIVE|cytotoxicity_AR/antagonism/partial	HTS_ACTIVE|cytotoxicity_ATAD5/activation	HTS_ACTIVE|cytotoxicity_AhR/agonism	HTS_ACTIVE|cytotoxicity_ER/antagonism/full	HTS_ACTIVE|cytotoxicity_FXR/antagonism	HTS_ACTIVE|cytotoxicity_H2AX/activation	HTS_ACTIVE|cytotoxicity_MMP/inhibition	HTS_ACTIVE|cytotoxicity_RORr/antagonism	HTS_ACTIVE|cytotoxicity_RSP/agonism	HTS_ACTIVE|cytotoxicity_RXR/agonism	HTS_ACTIVE|cytotoxicity_TR/antagonism	HTS_ACTIVE|cytotoxicity_VDR/agonism	HTS_ACTIVE|cytotoxicity_aromatase/inhibition	HTS_ACTIVE|inhibition_MMP	LEADSCOPE_TOXICITY|Developmental Toxicity-post impl. loss mouse	LEADSCOPE_TOXICITY|Developmental Toxicity-pre impl. loss mouse	LEADSCOPE_TOXICITY|Developmental Toxicity-pre impl. loss rabbit	LEADSCOPE_TOXICITY|Developmental Toxicity-structural rat	LEADSCOPE_TOXICITY|Developmental Toxicity-structural rodent	LEADSCOPE_TOXICITY|Developmental Toxicity-visceral rat	LEADSCOPE_TOXICITY|Developmental Toxicity-visceral rodent	LEADSCOPE_TOXICITY|Developmental Toxicity-weight dec. mouse	LEADSCOPE_TOXICITY|Developmental Toxicity-weight dec. rat	LEADSCOPE_TOXICITY|Genetic Toxicity -E. coli	LEADSCOPE_TOXICITY|Genetic Toxicity -E. coli w	LEADSCOPE_TOXICITY|Genetic Toxicity -In vitro chrom. ab. CHL	LEADSCOPE_TOXICITY|Genetic Toxicity -In vitro chrom. ab. CHO	LEADSCOPE_TOXICITY|Genetic Toxicity -In vitro chrom. ab. HL cells	LEADSCOPE_TOXICITY|Genetic Toxicity -In vitro chrom. ab. other cells	LEADSCOPE_TOXICITY|Genetic Toxicity -In vitro composite	LEADSCOPE_TOXICITY|Genetic Toxicity -SCE in vitro	LEADSCOPE_TOXICITY|Genetic Toxicity -SCE in vitro CHO	LEADSCOPE_TOXICITY|Genetic Toxicity -SCE in vitro other cells	LEADSCOPE_TOXICITY|Genetic Toxicity -UDS	LEADSCOPE_TOXICITY|Genetic Toxicity -UDS human lymphocytes	LEADSCOPE_TOXICITY|Genetic Toxicity -UDS rat hepatocytes	LEADSCOPE_TOXICITY|Genetic Toxicity -chrom. ab.	LEADSCOPE_TOXICITY|Genetic Toxicity -drosophila HT	LEADSCOPE_TOXICITY|Genetic Toxicity -drosophila SLRL	LEADSCOPE_TOXICITY|Genetic Toxicity -hgprt	LEADSCOPE_TOXICITY|Genetic Toxicity -microbial	LEADSCOPE_TOXICITY|Genetic Toxicity -micronucleus mouse	LEADSCOPE_TOXICITY|Genetic Toxicity -mouse lymphoma	LEADSCOPE_TOXICITY|Genetic Toxicity -s. cerevisiae	LEADSCOPE_TOXICITY|Genetic Toxicity -salmonella	LEADSCOPE_TOXICITY|Genetic Toxicity -yeast	LEADSCOPE_TOXICITY|Neurotoxicityy-pup behavior rodent	LEADSCOPE_TOXICITY|Reproductive Toxicity -sperm rat	LEADSCOPE_TOXICITY|Reproductive Toxicity -sperm rodent	LEADSCOPE_TOXICITY|Reproductive Toxicity- C3H10T1-2	LEADSCOPE_TOXICITY|Reproductive Toxicity- sperm mouse	LEADSCOPE_TOXICITY|Reproductive Toxicity-SHE	LEADSCOPE_TOXICITY|Reproductive Toxicity-carc mouse male	LEADSCOPE_TOXICITY|Reproductive Toxicity-carc rat	LEADSCOPE_TOXICITY|Reproductive Toxicity-carc rat female	LEADSCOPE_TOXICITY|Reproductive Toxicity-carc rat male	LEADSCOPE_TOXICITY|Reproductive Toxicity-carc rodent	LEADSCOPE_TOXICITY|Reproductive Toxicity-cell transformation	MESH|4-Aminopyridine	MESH|Amines	MESH|Aminopyridines	MESH|Aniline Compounds	MESH|Benzene Derivatives	MESH|Diamines	MESH|Heterocyclic Compounds	MESH|Heterocyclic Compounds, 1-Ring	MESH|Hydrocarbons	MESH|Hydrocarbons, Aromatic	MESH|Hydrocarbons, Cyclic	MESH|Nitrosamines	MESH|Nitroso Compounds	MESH|Organic Chemicals	MESH|Phenylenediamines	MESH|Polyamines	MESH|Pyridines	MESH|Rosaniline Dyes	MESH|Tetramethylphenylenediamine	MESH|Toluene	MESH|Toluidines	MESH|p-Dimethylaminoazobenzene	MULTICASE_TOX_PREDICTION|ARE activation in keratinocytes at 100uM	MULTICASE_TOX_PREDICTION|ARE activation in keratinocytes at 1mM	MULTICASE_TOX_PREDICTION|Allergic contact dermatitis, guinea pig and human	MULTICASE_TOX_PREDICTION|BSEP inhibition at 10uM	MULTICASE_TOX_PREDICTION|Dendritic cell activation at 100uM (CD86, CD54)	MULTICASE_TOX_PREDICTION|Draize eye irritation test, rabbit	MULTICASE_TOX_PREDICTION|Draize skin test, 24h, rabbit	MULTICASE_TOX_PREDICTION|Haptenation (DPRA, SH test)	MULTICASE_TOX_PREDICTION|Human oral bioavailability, F > 65% as actives	MULTICASE_TOX_PREDICTION|Human plasma protein binding, %bound	MULTICASE_TOX_PREDICTION|Local lymph node assay, mouse, extreme sensitizers (EC3 < 1%)	MULTICASE_TOX_PREDICTION|Local lymph node assay, mouse, moderate sensitizers (EC3 < 10%)	MULTICASE_TOX_PREDICTION|Local lymph node assay, mouse, weak sensitizers (EC3 < 100%)	MULTICASE_TOX_PREDICTION|MCT1 inhibition at 10uM	MULTICASE_TOX_PREDICTION|MDR1 inhibition at 10uM	MULTICASE_TOX_PREDICTION|MRP1 inhibition at 10uM	MULTICASE_TOX_PREDICTION|MRP2 substrates	MULTICASE_TOX_PREDICTION|MRP5 inhibition at 50uM	MULTICASE_TOX_PREDICTION|OATP2B1 inhibition at 100uM	MULTICASE_TOX_PREDICTION|RCA fetal death, mouse	MULTICASE_TOX_PREDICTION|RCA fetal death, rodent	MULTICASE_TOX_PREDICTION|RCA fetal dysmorphogenesis, rat	MULTICASE_TOX_PREDICTION|RCA fetal dysmorphogenesis, rodent	MULTICASE_TOX_PREDICTION|RCA human cholestasis	MULTICASE_TOX_PREDICTION|RCA survival pre-implantation, rodent	MULTICASE_TOX_PREDICTION|Tox21 ARE activation assay, only strong actives by NIEHS calls, research only	MULTICASE_TOX_PREDICTION|Tox21 ARE activation assay, strong and weak actives by NIEHS calls, research only	PHARMACTIONLIST|Carcinogens	PHARMACTIONLIST|Chemical Actions and Uses	PHARMACTIONLIST|Coloring Agents	PHARMACTIONLIST|Noxae	PHARMACTIONLIST|Specialty Uses of Chemicals	PHARMACTIONLIST|Toxic Actions	TOXCAST_ACTIVE|ATG_ERE_CIS_up	TOXCAST_ACTIVE|ATG_ERa_TRANS_up	TOXCAST_ACTIVE|ATG_PXRE_CIS_up	TOXCAST_ACTIVE|ATG_RXRb_TRANS_up	TOXCAST_ACTIVE|BSK_4H_MCP1_up	TOXCAST_ACTIVE|BSK_KF3CT_MCP1_down	TOXCAST_ACTIVE|BSK_LPS_IL1a_up	TOXCAST_ACTIVE|Tox21_AhR	TOXCAST_ACTIVE|Tox21_ERa_LUC_BG1_Agonist	TOXPRINT_STRUCTURE|bond:CN_amine_aliphatic_generic	TOXPRINT_STRUCTURE|bond:CN_amine_aromatic_generic	TOXPRINT_STRUCTURE|bond:CN_amine_pri-NH2_aromatic	TOXPRINT_STRUCTURE|bond:CN_amine_pri-NH2_generic	TOXPRINT_STRUCTURE|bond:CN_amine_ter-N_aliphatic	TOXPRINT_STRUCTURE|bond:CN_amine_ter-N_aromatic	TOXPRINT_STRUCTURE|bond:CN_amine_ter-N_aromatic_aliphatic	TOXPRINT_STRUCTURE|bond:CN_amine_ter-N_generic	TOXPRINT_STRUCTURE|bond:N=N_azo_aromatic	TOXPRINT_STRUCTURE|bond:N=N_azo_generic	TOXPRINT_STRUCTURE|bond:N=O_N-nitroso	TOXPRINT_STRUCTURE|bond:N=O_N-nitroso_generic	TOXPRINT_STRUCTURE|bond:NO_amino_oxy_generic	TOXPRINT_STRUCTURE|chain:aromaticAlkane_Ar-C-Ar	TOXPRINT_STRUCTURE|chain:aromaticAlkane_Ph-C1-Ph	TOXPRINT_STRUCTURE|chain:aromaticAlkane_Ph-C1_acyclic_connect_H_gt_1	TOXPRINT_STRUCTURE|chain:aromaticAlkane_Ph-C1_acyclic_connect_noDblBd	TOXPRINT_STRUCTURE|chain:aromaticAlkane_Ph-C1_acyclic_generic	TOXPRINT_STRUCTURE|ring:aromatic_benzene	TOXPRINT_STRUCTURE|ring:aromatic_phenyl	TOXPRINT_STRUCTURE|ring:hetero_[6]_N_pyridine	TOXPRINT_STRUCTURE|ring:hetero_[6]_N_pyridine_generic	TOXPRINT_STRUCTURE|ring:hetero_[6]_Z_1-	TOXPRINT_STRUCTURE|ring:hetero_[6]_Z_generic	TOXREFDB|CHR_mouse_	TOXREFDB|CHR_mouse_SystemicCarcinogenic	TOXREFDB|CHR_mouse_SystemicCarcinogenic_adult_PathologyNeoplastic	TOXREFDB|CHR_mouse_SystemicCarcinogenic_adult_PathologyNeoplastic_PrimaryDigestive	TOXREFDB|CHR_mouse_SystemicCarcinogenic_adult_PathologyNeoplastic_PrimaryDigestive_Stomach	TOXREFDB|CHR_mouse_SystemicCarcinogenic_adult_PathologyProliferative	TOXREFDB|CHR_mouse_SystemicCarcinogenic_adult_PathologyProliferative_PrimaryDigestive	TOXREFDB|CHR_mouse_SystemicCarcinogenic_adult_PathologyProliferative_PrimaryDigestive_Stomach	TOXREFDB|CHR_mouse_SystemicCarcinogenic_adult_PrimaryDigestive_Stomach	TOXREFDB|CHR_rat_SystemicCarcinogenic	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_AccessoryDigestive_Liver	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_Lymphatic_Spleen	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_PathologyNeoplastic	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_PathologyNeoplastic_Lymphatic	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_PathologyNeoplastic_Lymphatic_Spleen	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_PathologyNonProliferative	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_PathologyNonProliferative_AccessoryDigestive	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_PathologyNonProliferative_AccessoryDigestive_Liver	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_PathologyNonProliferative_Lymphatic	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_PathologyNonProliferative_Lymphatic_Spleen	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_PathologyProliferative	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_PathologyProliferative_Lymphatic	TOXREFDB|CHR_rat_SystemicCarcinogenic_adult_PathologyProliferative_Lymphatic_Spleen	TOXREFDB|SUB_mouse_	TOXREFDB|SUB_mouse_SystemicCarcinogenic	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_AccessoryDigestive_Liver	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_Lymphatic_Spleen	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_OtherSystemic	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations_BodyWeight	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyGross	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyGross_Lymphatic	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyGross_Lymphatic_Spleen	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyNonProliferative	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyNonProliferative_AccessoryDigestive	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyNonProliferative_AccessoryDigestive_Liver	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyNonProliferative_Lymphatic	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyNonProliferative_Lymphatic_Spleen	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyNonProliferative_Urinary	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyNonProliferative_Urinary_Kidney	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyProliferative	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyProliferative_AccessoryDigestive	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyProliferative_AccessoryDigestive_Liver	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyProliferative_Lymphatic	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_PathologyProliferative_Lymphatic_Spleen	TOXREFDB|SUB_mouse_SystemicCarcinogenic_adult_Urinary_Kidney	TOXREFDB|SUB_rat_DevelopmentalReproductive	TOXREFDB|SUB_rat_DevelopmentalReproductive_adult	TOXREFDB|SUB_rat_DevelopmentalReproductive_adult_PathologyNonProliferative	TOXREFDB|SUB_rat_DevelopmentalReproductive_adult_PathologyNonProliferative_ReproductiveMale	TOXREFDB|SUB_rat_DevelopmentalReproductive_adult_PathologyNonProliferative_ReproductiveMale_Testis	TOXREFDB|SUB_rat_DevelopmentalReproductive_adult_ReproductiveMale_Testis	TOXREFDB|SUB_rat_SystemicCarcinogenic	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_AccessoryDigestive_Liver	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_Lymphatic_Spleen	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_OtherSystemic	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations_BodyWeight	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyGross	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyGross_Lymphatic	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyGross_Lymphatic_Spleen	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyNonProliferative	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyNonProliferative_AccessoryDigestive	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyNonProliferative_AccessoryDigestive_Liver	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyNonProliferative_Lymphatic	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyNonProliferative_Lymphatic_Spleen	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyNonProliferative_Urinary	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyNonProliferative_Urinary_Kidney	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyProliferative	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyProliferative_Lymphatic	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyProliferative_Lymphatic_Spleen	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_PathologyProliferative_Skeletal	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_Skeletal_BoneMarrow	TOXREFDB|SUB_rat_SystemicCarcinogenic_adult_Urinary_Kidney
99-98-9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	1	1	0	0	0	1	0	0	0	1	1	1	1	0	1	1	1	1	0	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	1	0	1	1	1	1	1	1	1	1	1	0	1	0	1	1	0	1	0	1	0	1	0	0	1	0	1	0	0	0	0	0	0	0	1	0	1	0	1	0	1	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	1	1	1	0	0	0	0	0	1	0	0	1	1	1	1	1	1	1	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
99-97-8	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	1	0	0	1	0	0	1	0	0	0	0	0	1	1	0	0	0	1	1	1	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	1	0	1	0	1	1	1	1	0	1	0	1	1	0	0	0	0	0	0	1	1	1	0	0	0	0	1	1	1	1	1	1	0	1	0	0	0	0	0	1	0	1	0	1	1	0	1	1	1	1	0	1	1	1	0	1	0	0	0	1	1	1	0	1	0	0	1	0	0	1	1	1	1	0	1	1	1	1	0	0	0	1	1	1	0	1	1	1	1	1	1	0	1	0	0	1	1	1	1	0	1	0	0	1	1	0	0	0	0	1	0	0	0	1	1	1	1	0	1	1	1	1	1	0	0	0	1	1	1	0	0	1	1	1	0	1	1	0	0	1	1	0	0	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	1	0	0	0	0	0	1	1	0	0	1	1	1	0	0	0	1	1	0	1	1	1	1	1	1	0	0	1	1	0	0	0	0	0	0	0	1	0	1	0	1	1	0	0	0	1	1	1	0	0	1	0	0	0	0	0	1	1	0	1	1	0	0	0	0	0	0	1	0	0	1	1	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	0	1	1	1	1	0	0	1	1	1	1	0	0	0	0	0	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
60-11-7	0	0	1	0	1	1	0	0	1	0	0	0	1	1	0	1	0	0	0	0	0	1	1	0	1	0	1	1	1	0	1	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	1	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	1	0	0	1	0	0	0	0	0	1	0	1	0	0	0	1	1	0	0	1	0	0	0	0	1	0	1	0	0	0	0	0	0	1	0	0	1	0	1	1	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	1	1	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	1	1	1	1	0	1	1	1	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	1	1	1	1	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	1	1	0	1	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	1	1	1	1	1	0	1	0	1	1	0	1	0	1	0	1	0	0	0	0	1	0	0	0	1	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	1	1	0	1	0	0	1	1	1	0	1	1	1	1	1	1	1	1	0	0	0	0	0	0	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	1	1	0	0	1	1	1	1	1	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1122-58-3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	1	1	0	0	0	0	1	0	0	0	0	0	0	1	1	1	0	0	0	1	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	1	0	0	0	1	0	0	1	0	0	1	1	1	0	1	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
129-73-7	1	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	1	0	0	1	0	0	0	1	0	0	1	0	0	0	1	0	1	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	1	1	1	0	0	0	0	1	1	0	0	0	0	1	0	0	0	0	1	0	0	0	1	1	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	1	1	1	0	1	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	1	1	0	0	0	0	0	0	1	0	0	1	1	1	1	1	1	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	1	1	1	0	0	0	0	0	1	1	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
614-00-6	0	1	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0	0	1	1	1	1	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0	1	1	1	0	0	0	1	1	0	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	1	0	1	1	1	1	0	1	1	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
121-69-7	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	0	0	0	0	1	0	1	0	0	0	1	1	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	1	1	1	1	1	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	1	0	0	1	0	1	0	0	1	1	1	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
121-72-2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
100-22-1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	1	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	1	0	1	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	1	1	1	1	1	1	0	0	0	0	1	1	0	1	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	0	0	0	0	1	1	1	0	0	1	0	0	0	1	1	0	0	0	0	0	0	1	0	0	1	1	1	1	1	1	1	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
